Pharmacokinetic/Toxicity Properties of the New Anti-Staphylococcal Lead Compound SK-03-92
Because of the potential of a new anti-staphylococcal lead compound SK-03-92 as a topical antibiotic, a patch, or an orally active drug, we sought to determine its safety profile and oral bioavailability. SK-03-92 had a high IC50 (125 μg/mL) in vitro against several mammalian cell lines, and mice in...
Saved in:
Main Authors: | William R. Schwan (Author), Jill M. Kolesar (Author), M. Shahjahan Kabir (Author), Edmund J. Elder (Author), Jeffrey B. Williams (Author), Rachel Minerath (Author), James M. Cook (Author), Christopher M. Witzigmann (Author), Aaron Monte (Author), Tricia Flaherty (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2015-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Identification of Staphylococcus aureus Cellular Pathways Affected by the Stilbenoid Lead Drug SK-03-92 Using a Microarray
by: William R. Schwan, et al.
Published: (2017) -
SK-03-92 Drug Kills Intracellular <i>Mycobacterium tuberculosis</i>
by: William R. Schwan
Published: (2023) -
Spontaneous staphylococcal peritonitis: A case report
by: Aaron Osman, et al.
Published: (2023) -
پاییز 92
Published: (2013) -
تابستان 92
Published: (2013)